fluoxetine has been researched along with lofepramine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blakely, RD; Groshan, K; Richelson, E; Tatsumi, M | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Dean, A; Jick, H; Ulcickas, M | 1 |
| Seymour, J; Wattis, JP | 1 |
| Abou-Saleh, MT; Burns, RA; Edwards, DR; Harrison, DA; Horton, RW; Katona, CL; Lawrence, KM; Lock, T; Nairac, BL; Robertson, MM | 1 |
| Abou-Saleh, MT; Burns, RA; Edwards, DR; Harrison, DA; Katona, CL; Lock, T; Nairac, BA; Robertson, MM | 1 |
| Abou-Saleh, MT; Burns, R; Edwards, DR; Harrison, DA; Katona, CL; Lock, T; Nairac, BL; Robertson, MM; Taylor, NS | 1 |
| Abou-Saleh, MT; Burns, RA; Edwards, DR; Harrison, DA; Katona, CL; Lock, T; Nairac, B; Robertson, MM | 1 |
| Baker, R; Enriquez-Puga, A; Paul, S; Villoro-Valdes, R | 1 |
5 trial(s) available for fluoxetine and lofepramine
| Article | Year |
|---|---|
Platelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine.
Topics: Adolescent; Adult; Aged; Blood Platelets; Cell Membrane; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Lofepramine; Male; Middle Aged; Paroxetine; Receptors, Serotonin | 1994 |
Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.
Topics: Adolescent; Adult; Aged; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium Carbonate; Lofepramine; Male; Middle Aged | 1995 |
Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.
Topics: Depressive Disorder; Drug Therapy, Combination; Fluoxetine; Humans; Lithium; Lofepramine | 1993 |
Predictors of response to amine-specific antidepressants.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Lofepramine; Male; Middle Aged; Personality Inventory; Treatment Outcome | 1995 |
Effect of educational outreach on general practice prescribing of antibiotics and antidepressants: a two-year randomised controlled trial.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Child; Drug Prescriptions; Education, Medical, Continuing; Family Practice; Female; Fluoxetine; Follow-Up Studies; Guideline Adherence; Humans; Lofepramine; Male; Outcome Assessment, Health Care; Physicians, Family; Practice Patterns, Physicians'; Quinolones; Single-Blind Method | 2009 |
8 other study(ies) available for fluoxetine and lofepramine
| Article | Year |
|---|---|
Pharmacological profile of antidepressants and related compounds at human monoamine transporters.
Topics: Antidepressive Agents; Brain; Carrier Proteins; Cell Line; Dopamine Plasma Membrane Transport Proteins; Humans; In Vitro Techniques; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; Protein Binding; Radioligand Assay; Serotonin Plasma Membrane Transport Proteins; Symporters; Synaptosomes | 1997 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of frequencies of suicidal tendencies among patients receiving fluoxetine, lofepramine, mianserin, or trazodone.
Topics: Adolescent; Adult; Aged; Fluoxetine; Humans; Lofepramine; Mianserin; Middle Aged; Suicide; Suicide, Attempted; Trazodone; United Kingdom | 1992 |
Treatment resistant depression in the elderly: three cases.
Topics: Aged; Aged, 80 and over; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium; Lofepramine; Male | 1992 |